Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

European Patient Summary

Patient
Name: Begum, , Bethany,
DOB: 19-JAN-1976 (Age: 49)
Gender: female
ID: 2365-936148-1 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 03-MAY-2025

Problem list

Condition Onset Date Status
Hyperlipidemia 12-Apr-2024 active
Prediabetes 30-Mar-2007 active
Chronic sinusitis 28-Oct-2005 active

Medication list

Medication Since Form Dosage Reason
Simvastatin 10 mg oral tablet 2025-05-03 - 1 tablet (10 mg) by mouth once daily Hyperlipidemia
72 HR Fentanyl 0.025 MG/HR Transdermal System 2025-04-18 - Apply 1 patch (0.025 mg/hr) every 72 hours -
Acetaminophen 300 mg and codeine phosphate 15 mg oral tablet 2025-04-18 - 1 tablet (300 mg/15 mg) every 4 to 6 hours as needed for pain -
Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin] 2025-04-18 - 1 tablet (10 mg) every 12 hours -
12 HR Hydrocodone Bitartrate 10 MG Extended Release Oral Capsule 2025-04-18 - 1 capsule (10 mg) every 12 hours -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 18-Apr-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 12-Apr-2024
Live attenuated Human alphaherpesvirus 3 only vaccine product 12-Apr-2024

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Live attenuated Varicella-zoster vaccine ? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Hyperlipidemia clinical management plan 03-May-2024 Hyperlipidemia
  • Achieve LDL cholesterol less than 100 mg/dL
  • Achieve total cholesterol less than 200 mg/dL
  • Achieve HDL cholesterol greater than 50 mg/dL
  • Achieve triglycerides less than 150 mg/dL
Therapy 18-Mar-2014 -
Diabetes self management plan 30-Mar-2007 Prediabetes
  • Patient will implement and maintain a diabetes self-management plan to reduce risk of progression to diabetes.

Vital Signs

Vital Signs 2025-04-18 2024-04-12
Body Height 151.1 cm 151.1 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 1 {score}
Body Weight 63.6 kg 63.6 kg
Body mass index (BMI) [Ratio] 27.9 kg/m2 27.9 kg/m2
Diastolic Blood Pressure 83 mm[Hg] 82 mm[Hg]
Systolic Blood Pressure 111 mm[Hg] 106 mm[Hg]
Heart rate 100 /min 95 /min
Respiratory rate 16 /min 15 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 03-MAY-2025 Reference Range Unit
Glucose [Mass/volume] in Blood 73.9 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.3 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 3.4 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.7 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.3 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 105.7 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.3 22 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.8 6.3 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.8 3.5 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 3.2 2 - 3.9 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.1 L 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 23.2 L 32 - 104 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 45.4 7 - 55 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.6 10 - 40 U/L
Cholesterol [Mass/volume] in Serum or Plasma 208.4 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 121.5 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 149.5 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.0 40 - 60 mg/dL

Device Use

Device Date (since)
Blood glucose meter (physical object) 30-Mar-2007
Home nebulizer (physical object) 28-Oct-2005